The webcast of the live call may be accessed on the Investors section of the iBio website at ir.ibioinc.com/news-events/ir-calendar. A replay of the webcast will be available on the iBio website for ...

One-year results from the company's FORWARD-101 trial of islet cell therapy zimislecel (also known as VX-880) showed that all ...

Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression ...

A dozen volunteers with severe type 1 diabetes showed clear improvements in their condition 12 months after receiving a ...

Type 1 diabetes is an autoimmune disease in which the immune system attacks insulin-producing beta cells of pancreatic islets. Type 1 diabetes can be treated with islet transplantation; however, ...

Type 1 diabetes (T1D) is an autoimmune condition where the immune system destroys insulin-producing β-cells in the pancreas.

USA: People diagnosed with celiac disease or thyroid disorders may be at significantly increased risk of developing type 1 ...

These antibodies, which recognize and confer protection against foreign objects (antigens), can be non-neutralizing or neutralizing antibodies. Non-neutralizing antibodies (nNAbs), also known as ...

Increased expression of IL5-Ra in such patients is proposed to have a role in local antibody production and is correlated with disease severity and recurrence of nasal polyposis. 71,72 That IL-5Ra ...

Objective To compare acute treatment responses and long-term outcome in leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis. Methods Retrospective case series of 118 patients with LGI1 ...

Get Instant Summarized Text (Gist) A membrane protein, FXYD2, has been identified as a marker that distinguishes functional, mature stem cell–derived islet organoids from non-functional ones.